Author Affiliation: Department of Epidemiology and Public Health, Institute of Health Equity at University College, London, England.
Views on the benefits and harms of breast cancer screening are sharply polarized and increasingly vocal. Allegations of harming women are flung in both directions. The antiscreeners claim that benefit is minimal and overdiagnosis is so frequent that women are being subject to unnecessary interventions and treatment. The proscreeners claim that if the critics win the day, women will be deprived of the benefits that screening brings of early diagnosis and reductions in mortality from breast cancer.
Marmot MG. Sorting Through the Arguments on Breast Screening. JAMA. 2013;309(24):2553–2554. doi:10.1001/jama.2013.6822
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.